Takeshi Isobe

2.9k total citations
130 papers, 2.2k citations indexed

About

Takeshi Isobe is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Takeshi Isobe has authored 130 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Pulmonary and Respiratory Medicine, 49 papers in Oncology and 26 papers in Molecular Biology. Recurrent topics in Takeshi Isobe's work include Lung Cancer Treatments and Mutations (38 papers), Lung Cancer Diagnosis and Treatment (17 papers) and Lung Cancer Research Studies (17 papers). Takeshi Isobe is often cited by papers focused on Lung Cancer Treatments and Mutations (38 papers), Lung Cancer Diagnosis and Treatment (17 papers) and Lung Cancer Research Studies (17 papers). Takeshi Isobe collaborates with scholars based in Japan, United States and United Kingdom. Takeshi Isobe's co-authors include Tetsuya Oguri, Yukari Tsubata, Nobuoki Kohno, Amir Onn, Roy S. Herbst, Michio Yamakido, Michael S. O’Reilly, Isaiah J. Fidler, Kazunori Fujitaka and Ryosuke Tanino and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Takeshi Isobe

119 papers receiving 2.1k citations

Peers

Takeshi Isobe
David Trent United States
John W. Kugler United States
Takeshi Isobe
Citations per year, relative to Takeshi Isobe Takeshi Isobe (= 1×) peers Peter Naredi

Countries citing papers authored by Takeshi Isobe

Since Specialization
Citations

This map shows the geographic impact of Takeshi Isobe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Isobe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Isobe more than expected).

Fields of papers citing papers by Takeshi Isobe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Isobe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Isobe. The network helps show where Takeshi Isobe may publish in the future.

Co-authorship network of co-authors of Takeshi Isobe

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Isobe. A scholar is included among the top collaborators of Takeshi Isobe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Isobe. Takeshi Isobe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Furuya, Naoki, T Hotta, Toshihide Yokoyama, et al.. (2025). Arterial Thromboembolism in Patients With Advanced Lung Cancer: Secondary Analyses of the Rising‐ VTE / NEJ037 Study. Cancer Medicine. 14(1). e70568–e70568. 1 indexed citations
2.
Hotta, T, et al.. (2023). Lipoid Pneumonia Caused by Esophageal Achalasia. Internal Medicine. 63(3). 443–446.
3.
Okimoto, Tamio, et al.. (2023). An 83‐year‐old patient with RET fusion‐positive non‐small cell lung cancer experiencing severe hepatic disorder due to selpercatinib administration. SHILAP Revista de lepidopterología. 11(5). e01136–e01136. 3 indexed citations
4.
Tanino, Ryosuke, Yukari Tsubata, T Hotta, et al.. (2023). Characterization of a spontaneous mouse model of mild, accelerated aging via ECM degradation in emphysematous lungs. Scientific Reports. 13(1). 10740–10740.
5.
Tsubata, Yukari, Kosuke Hamai, Naoki Furuya, et al.. (2022). Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data. International Journal of Clinical Oncology. 28(1). 69–78. 11 indexed citations
6.
Hotta, T, et al.. (2020). Comparative postoperative outcomes of GGN-dominant vs single lesion lung adenocarcinomas. Journal of Cardiothoracic Surgery. 15(1). 149–149. 5 indexed citations
7.
Tanino, Ryosuke, Rong Sun, Yukari Tsubata, et al.. (2019). Anticancer Activity of ZnO Nanoparticles against Human Small-Cell Lung Cancer in an Orthotopic Mouse Model. Molecular Cancer Therapeutics. 19(2). 502–512. 86 indexed citations
8.
Tanino, Ryosuke, et al.. (2019). Protein tyrosine kinase 2: a novel therapeutic target to overcome acquired EGFR-TKI resistance in non-small cell lung cancer. Respiratory Research. 20(1). 270–270. 36 indexed citations
9.
Tada, Mitsuhiro, et al.. (2014). Comparison of clinical management of young and elderly asthmatics by respiratory specialists and general practitioners. Journal of Asthma. 52(2). 162–169. 7 indexed citations
10.
Chen, Lijun, Yasuyuki Taooka, Hitoshi Takahashi, et al.. (2013). Cyclooxygenase 2 1195G>A polymorphism is associated with chronic obstructive pulmonary disease in Japanese and Chinese patients. Chinese Medical Journal. 126(12). 2215–2221. 4 indexed citations
11.
Isobe, Takeshi, Amir Onn, Daniel Morgensztern, et al.. (2013). Evaluation of Novel Orthotopic Nude Mouse Models for Human Small-Cell Lung Cancer. Journal of Thoracic Oncology. 8(2). 140–146. 26 indexed citations
12.
Iwamoto, Shinichi, et al.. (2012). Bronchoscopic Electrosurgical Snaring to Prevent Suffocation After Laryngeal Artery Embolization Caused Multifocal Airway Stenosis Due to Endobronchial Metastasis from Colon Cancer. 34(6). 604–610.
13.
Tsubata, Yukari, Akinobu Hamada, Akihisa Sutani, & Takeshi Isobe. (2012). Erlotinib-induced acute interstitial lung disease associated with extreme elevation of the plasma concentration in an elderly non-small-cell lung cancer patient. Journal of Cancer Research and Therapeutics. 8(1). 154–154. 18 indexed citations
14.
Yokose, Tomoyuki, Yuji Sakuma, Yohei Miyagi, et al.. (2012). Stromal micropapillary component as a novel unfavorable prognostic factor of lung adenocarcinoma. Diagnostic Pathology. 7(1). 3–3. 19 indexed citations
15.
Tsubata, Yukari, Takeshi Honda, Tamio Okimoto, et al.. (2012). A retrospective analysis comparing the safety and efficacy of chemotherapy in elderly and non‐elderly non‐small‐cell lung cancer patients. Geriatrics and gerontology international. 12(3). 499–505. 2 indexed citations
16.
Isobe, Takeshi. (2009). Guidelines for Respiratory Tract Diseases. Nihon Naika Gakkai Zasshi. 98(8). 2014–2022. 1 indexed citations
17.
Kurata, Takayasu, Tetsuya Oguri, Takeshi Isobe, Shinichi Ishioka, & Michio Yamakido. (1999). Differential Expression of Facilitative Glucose Transporter (GLUT) Genes in Primary Lung Cancers and Their Liver Metastases. Japanese Journal of Cancer Research. 90(11). 1238–1243. 85 indexed citations
18.
Syahruddin, Elisna, Tetsuya Oguri, Toshiaki Takahashi, et al.. (1998). Differential Expression of DNA Topoisomerase IIα and IIβ Genes between Small Cell and Non‐small Cell Lung Cancer. Japanese Journal of Cancer Research. 89(8). 855–861. 13 indexed citations
19.
Isobe, Takeshi, Kouzo Yamada, Fumihiro Oshita, et al.. (1995). CT Analysis of Resected Lung Carcinomas Less than 1.5cm in Diameter.. Haigan. 35(7). 891–899. 2 indexed citations
20.
Isobe, Takeshi, Keiko Hiyama, Yasuhiro Yoshida, Yasuhiro Fujiwara, & Michio Yamakido. (1994). Prognostic Significance of p53 and ras Gene Abnormalities in Lung Adenocarcinoma Patients with Stage I Disease after Curative Resection. Japanese Journal of Cancer Research. 85(12). 1240–1246. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026